Transformation of mesenchymal stem cells by the retrovirus-mediated gene transfer 1 Department of Drthopaedeic Surgery Kyoto University,Kyoto,Japan 2 Institute.

Slides:



Advertisements
Similar presentations
Cancer—Principles and overview By Robert A. Weinberg
Advertisements

Kwee Yong, UCL Cancer Institute
The relative contribution of microenvironmental interactions to the regulation of gene expression programs in multiple myeloma cells Liat Nadav Molecular.
Niko Bla ž evi ć Mentor: A. Ž mega č Horvat.  The process of transformation from a normal cell to a cancerous one  Synonym: neoplasia Carcin ogenes.
Gene-Expression Pattern and Differentiation Potential of Synovial Sarcoma Suggest its Cellular Origin as Neural Crest-Derived Cells Tatsuya Ishibe, Tomitaka.
Genetics of Adult Lung Cancer Frederic J. Kaye, M.D. Genetics Branch, CCR, NCI and National Naval Medical Center.
Introduction to Neoplasia
Telomeres and Telomerase in Aging and Cancer. Contents ★ Telomere & Telomerase & End of replication problem ★ Setting the Numver of Doublings ★ Senescence.
CANCER IS A GENETIC DISEASE SUPPORTING EVIDENCE: 1. Hereditary cancer 2. Cancer-causing virus 3. Alterations of cellular genes in cancer 4. Clonal development.
Mallory Demonch Biol 455 March 24, 2008
Chapter 3: Tumor Viruses Peyton Rous discovers a chicken sarcoma virus (1911)
Telomeres and Telomerase in Cancer Development 20 March 2008 Hannah Yin (
Stem Cell Basics Introduction to Embryonic and Adult Stem Cells.
Hallmarks of Cancer Six fundamental changes 1.Self sufficiency in growth factors 2.Insensitivity to growth-inhibitory signals 3.Evasion of apoptosis 4.Limitless.
C22 Cancer and the Immune System Cell births ~ cell deaths; production of new cells is regulated Cells that do not respond to normal growth controls can.
Please write your field of dissertation on the blank sheet.
Analysis of Transgenic Plants. 1.Regeneration on Selective Medium Selectable Marker Gene.
Tumor genetics Minna Thullberg
Transformation and Immortalization
Tumorigenesis and Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Cellular Senescence: A Link between Tumor Suppression and Organismal Aging.
Cancer Deregulation of cell cycle Loss of control of mitosis Result of mutation Over 200 types of cancer exists (Number of cancer cases will double by.
Tumorigenesis to Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Cloning in Nature Parthenogenesis Monozygotic twins (embryo splitting)
Cancer as a genetic chapter 21 pp & lecture notes.
Kyoto University, Japan
Chapter 3 Tumor Viruses 3.1, 3.2, Mar 15, 2007.
12 th Annual CTOS Meeting Serum TRACP5B level in OSS. AvnetBologna 545.Stromal cell of GCTM. SalernoBologna 549.Gene expression in sarcomaD.E.
BRG-1 in Cancer BRG-1 is an ATPase subunit of the SWI/SNF class of chromatin remodeling complexes It has been found mutated in a number of cancer cell.
The Effect of N-Acetyl Cysteine on Myofibroblast Phenotype Expression by Immortalized Keratinocytes, Ker-CT-Ras Jessica M. Webb 1, Pritika Khadka 2, and.
Telomerase, Immortalization and Cancer Eric Bankaitis Cancer Bio 169 March 9, 2006 Fig.[9]
FIGURE Clonal Variation
5-2a: Cloning How are mammals cloned?
SS18-SSX IS A CELL-CONTEXT-DEPEDENT EPIGENETIC REGULATOR: IMPLICATION FOR CELL-OF-ORIGIN OF SYNOVIAL SARCOMAS Sakura Tamaki1,2, Makoto Fukuta1,2,3, Kazuo.
Cellular Therapies for Repair and Regeneration of Joint Surfaces— Product Characterization and Testing Malcolm Moos Jr., M.D., Ph.D. Medical Officer
Cell Therapy in CV Disease: Newest Evidence. 2 Induction of pluripotent stem cells from human fibroblasts Study Source of fibroblasts Transcription factors.
Bmi-1 in Cancer Cancer genetics 2012/04/ 전종철
The Biology of Cancer Second Edition CHAPTER 4 Cellular Oncogenes
c-Myc A Biological Paradox
Cancer as a genetic chapter 21 pp & lecture notes.
Signature_description
The Control of Gene Expression
IDENTIFICATION AND CHARACTERIZATION OF Cancer STEM CELLS IN CLEAR CELL
Wilms tumor cells with WT1-mutations have characteristic features of mesenchymal stem cells Maike Busch1, Constanze Duhme1, Artur Brandt1, Manfred Beier1,
Cancer as a genetic disease
Immortalization and characterization of mouse temporomandibular joint disc cell clones with capacity for multi-lineage differentiation  Y. Park, J. Hosomichi,
Telomerase activity in smooth‐muscle cells increases lifespan and extends telomeres. Telomerase activity in smooth‐muscle cells increases lifespan and.
(A) Outline of the malignant transformation process.
Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Cancer stem cells and their application into targeted therapy for cancer Mol. Bio. Lab Park Ji Won Supervisor ; Dae Youn Hwang.
What We Have Learned About Pancreatic Cancer From Mouse Models
Volume 47, Issue 2, Pages (July 2012)
Volume 17, Issue 4, Pages (April 2010)
Isolation of multipotent mesenchymal stem cells from umbilical cord blood by Oscar K. Lee, Tom K. Kuo, Wei-Ming Chen, Kuan-Der Lee, Shie-Liang Hsieh, and.
Mesenchymal stromal cell (MSC) phenotype from chronic obstructive pulmonary disease (COPD) and non-COPD patients. Mesenchymal stromal cell (MSC) phenotype.
Volume 17, Issue 4, Pages (April 2010)
Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma by Jerome T. Higgs, Joo Hyoung Lee,
Lung-derived mesenchymal stem cells (MSC) display in vitro multilineage potential. Lung-derived mesenchymal stem cells (MSC) display in vitro multilineage.
Volume 11, Issue 1, Pages (July 2012)
Volume 4, Issue 6, Pages (June 2015)
A Novel Type of EWS-CHOP Fusion Gene in Two Cases of Myxoid Liposarcoma  Taisuke Hosaka, Yasuaki Nakashima, Katsuyuki Kusuzaki, Hiroaki Murata, Tomitaka.
Volume 3, Issue 6, Pages (December 2014)
Cellular Pliancy and the Multistep Process of Tumorigenesis
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
Susan J. Clark, Peter L. Molloy  Cancer Cell 
Biomechanical force may promote tumor progression by establishing an aggressive tumor cell hierarchy. Biomechanical force may promote tumor progression.
Model of malignant transformation of in vitro HBECs following stepwise introduction of common lung cancer mutations. Model of malignant transformation.
AXL knockout does not prevent dormancy.
Presentation transcript:

Transformation of mesenchymal stem cells by the retrovirus-mediated gene transfer 1 Department of Drthopaedeic Surgery Kyoto University,Kyoto,Japan 2 Institute for Frontier Medical Sciences Kyoto University,Kyoto,Japan Yasuko Shima 1.2 Takeshi Okamoto 1.2 Tatsuya Ishibe 1.2 Koichi Nishijo 1.2 Tomoki Aoyama 2 Tomitaka Nakayama 1 Takashi Nakamura 1 Junya Toguchida 2

transformed cell normal cell Transformation of mammalian cells requires multiple steps SV40 hTERT H-ras 12V E6/E7 hTERT H-ras 12V normal cell transformed cell Escape from telomere shortening → telomerase expression → hTERT Escape from cell cycle regulation → k/o Rb etc → SV40, E7 Escape from programmed cell death → k/o p53 etc → SV40, E6 Gain of malignant phenotype → mutation of ras etc → H-ras 12V

MSC can be immortalized by the activation of hTERT? Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells Simonsen, J.L., ---, Kassem, M. Nature Biotech., 20: 592-6, 2002 MSC-hTERT MSC-Mock Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cellsOkamoto T., et al. BBRC., 295: , 2002 Immortalize hMSC by hTERT+HPVE6/E7

Time (days) Population Doubling Adult human mesenchymal stem cell as a target for neoplastic transformation Serakinci, N., ---, Kassem, M. Oncogene, 24: , 2004 Inactivation of p16 may be required to be immortalized Ink4a(p16)/ARF deletion Oncogenic K-ras mutation Ink4a(p16)/ARF deletion

Bmi-1 (B cell-specific Mo-MLV integration site 1) First isolated as an oncogene that cooperates with c-myc in the generation of mouse lymphomas. Required to maintain stable repression of target genes promotertranscription initiation site Bmi-1 polycomb response elements polycomb response elements promotertranscription initiation site transcription initiation complex

Immortalization of human MSC(hMSC) by the induction of Bmi1 hMSC -Bmi1-hT hMSC Bmi-1 hTERT p16-mRNA p16-Protein PD2PD9 hMSC -E6E7 -hT hMSC -Bmi1 -hT hMSC Control (Saos2)

Transformation of immortalized hMSC by the induction of activated H-ras 12V hMSC Bmi-1 hTERT H-ras 12V hMSC -Bmi1-hT “Parental” hMSC -Bmi1-hT -pQCXIP/H-ras 12V “pQCXIP/H-ras 12V ” 1.Anchorage-independent growth property colony formation in soft agar 2.Serum-independent growth property growth curves with 1% serum 3.Acquisition of invasiveness and motility matrigel invasion assay 4.Ability to make tumors subcutaneous tumorigenicity assay 5.Differentiation potential induction of adipo and osteo differentiation

endogenous H-ras (1.1kb) Parental Induction of pQCXIP/H-ras 12V into hMSC-Bmi1-hT cells X100 exogenous H-ras 12V (2.5kb) Parental 2. pQCXIP-1 3. pQCXIP-2 4. pQCXIP/H-ras 12V pQCXIP/H-ras 12V -2 Cell Morphology pQCXIP pQCXIP/H-ras 12V Northern Blot

Growth property with low serum condition * * * * 10% FBS * * * 1%FBS (×10 5 ) * : p<0.05 pQCXIP/H-ras 12V pQCXIP Parental pQCXIP/H-ras 12V pQCXIP Parental Cell Number Culture Days * : p<0.05

pQCXIP /H-ras 12V pQCXIP-1 pQCXIP/H-ras 12V -1 Colony formation assay in soft agar x40 colony/cell number Parental x40

x Cell motility (cell counts of control insert) cell number ParentalpQCXIP /H-ras 12V pQCXIP-1 pQCXIP-Hras 12V 1 x200

Parental Matrigel Invasion Assay x200 pQCXIP-2 pQCXIP-Hras 12V cell number pQCXIP /H-ras 12V x200

Tumorigenecity assay days volume(mm3) Right :pQCXIP/H-ras 12V Left :pQCXIP Inoculation pQCXIP/H-ras 12V -1 pQCXIP/H-ras 12V -2

Histopathology of the tumor

Induction (-) Induction (+) Parental Differentiation potential after induction of H-ras 12V ー Bone  -ACT ALP COLIA1 Induction w p.c. OC ras1ras2ras1ras2 Alizarin Red staining pQCXIP/H-ras 12V 2w3w

Oil-Red O staining x200 Induction (-) Induction (+) Parental pQCXIP/H-ras 12V Differentiation potential after induction of H-ras 12V- Adipo BACT p.c. PPARg induction Parental 1w2w3w - + BACT induction p.c. PPARg ras1ras2ras1ras w2w3w

1.Serum-independent growth property(+) 2.Anchorage-independent growth property(+) 3.Motility(+) 4.Invasiveness(+) 5.In vivo tumorigenesis(+) 6.Osteogenic differentiation(-) 7.Adipogenic differentiation? hMSC was transformed by hTERT+Bmi-1+H-ras V12 This is the first time to report of transformation by the combination of hTERT+Bmi1+H-ras 12V. Only against hMSC? hMSC is easy to transform?? What is the cause of sarcoma? Is there the gene equivalent of H-ras 12V ? hMSC-Bmi1-hTERT is usefull model to screen the sarcoma-related gnes hMSC Bmi-1 hTERT H-ras 12V undifferentiated sarcoma